Expert Insights
ETF Channels
ETF Strategist
ETF Building Blocks
Active ETF
ETF Education
Alternatives
Fixed Income
Beyond Basic Beta
Future ETFs
China Insights
Gold & Silver Investing
Core Strategies
Innovative ETFs
Crypto
Leveraged & Inverse
Disruptive Technology
Modern Alpha
Dividend
Multi-Factor
Emerging Markets
Multi-Asset
Energy Infrastructure
Nasdaq Investment Intelligence
Entrepreneur ETF
Portfolio Strategies
Equity ETF
Retirement Income
ESG
Smart Beta
Thematic Investing
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
ETF Education
First Bitcoin ETF
Newsletter
New ETFs
ETF Ecosystem
Education Central
ETF Playbook
ETFinTwit
Videos & Podcasts
Videos
ETF of the Week
ETF Prime Podcast
ETF 360 Video Series
Podcasts
Events
Exchange: An ETF Experience
ETFs Future-Forward 2021: An iShares Investing Symposium
Salix
Featured
Salix Bidding War Provides Modest Boost for Pharma ETFs
By
Todd Shriber
March 11, 2015
X
